Tag: Eli
Market: Eli Lilly’s star diabetes drug sees third-quarter profit
by Bhanvi Satija (Reuters) – Growing demand for Eli Lilly’s diabetes drug Mounjaro, also used for weight loss, generated a surprise third-quarter profit, but the U.S. drugmaker expects supply constraints…
Eli Lilly: FDA approves its treatment for ulcerative colitis – 10/27/2023 at 2:41 p.m.
(AOF) – Eli Lilly and Company announced today that the Food and Drug Administration (FDA) has approved Omvo (mirikizumab-mrkz) infusion for the treatment of moderately to severely active ulcerative colitis…
Eli Lilly files a complaint against the sale of counterfeits of its drug Mounjaro
(AOF) – Eli Lilly has filed a complaint with the United States International Trade Commission to block several companies from importing, selling or distributing what they represent as tirzepatide, the…
Eli Lilly: positive data around Verzenio
(CercleFinance.com) – Eli Lilly and Company presented the five-year results of a phase 3 study that evaluated for two years the administration of Verzenio® (abemaciclib) associated with endocrine therapy (ET)…
Eli Lilly files a complaint against the sale of counterfeits of its drug Mounjaro – 10/20/2023 at 2:37 p.m.
(AOF) – Eli Lilly has filed a complaint with the United States International Trade Commission to block several companies from importing, selling or distributing what they represent as tirzepatide, the…
Eli Lilly: encouraging data in atopic dermatitis
(CercleFinance.com) – Eli Lilly reports that patients with moderate to severe atopic dermatitis who received treatment with investigational lebrikizumab for up to two years experienced ‘sustained skin clearance, relief of…
With “Suits” and “Grey’s Anatomy” stars: Eli Roth turns his fake trailer “Thanksgiving” into a real horror shocker
ENTERTAINMENT September 8, 2023 at 11:45 a.m What began as a fake trailer 16 years ago will become a bloody reality this November. Eli Roth’s “Thanksgiving” opens in German cinemas,…
Eli Lilly: will share several results in oncology
(CercleFinance.com) – Eli Lilly announces the presentation of several studies at the congress of the European Society of Medical Oncology (ESMO) which will be held in Madrid from October 20…
Eli Lilly: several clinical results presented at the end of October in Madrid – 06/10/2023 at 2:22 p.m.
(AOF) – Eli Lilly and Company is expected to rise in the pre-market on Wall Street after announcing today that data from studies on its products Verzenio, Retevmo and imlunestrant…
Eli Lilly down on announcement of Point Biopharma Global takeover, cancer specialist
(AOF) – Eli Lilly (-2.28% to $522.97) is down slightly on Wall Street after the announcement of the takeover of the company Point Biopharma Global. Specializing in the development of…
Eli Lilly: the takeovers of Versanis and Sigilon are completed
(CercleFinance.com) – Eli Lilly announced on Monday that it had completed the acquisition of Versanis Bio, a biopharmaceutical company which it had formalized the acquisition last month for an amount…
Eli Lilly: stable with a brokerage raise
(CercleFinance.com) – The day after a jump of nearly 15%, Eli Lilly managed to maintain its equilibrium at the start of the session on Wall Street, supported by an increase…